The Biology of Classical Hodgkin Lymphoma
Article in Seminars in Hematology (May 2024)
The most recent citing publications are shown below. View all 45 publications that cite this research output on Dimensions.
Case report: Sustained complete remission with all-oral MEPED therapy in a patient with Hodgkin’s disease developing resistance to pembrolizumab
Article in Frontiers in Pharmacology (February 2024)
Not only a therapeutic target; mTOR in Hodgkin lymphoma and acute lymphoblastic leukemia
Article in Frontiers in Oncology (February 2024)